High-dose (HDS) chemotherapy in multiple myeloma: Residual tumor cells are detectable in PBPC and BM cell harvests and after single or double autografting.

被引：0
|
作者：
Corradini, P [1 ]
Astolfi, M [1 ]
Ladetto, M [1 ]
Campana, S [1 ]
Comoglio, F [1 ]
Tarella, C [1 ]
Boccadoro, M [1 ]
Pileri, A [1 ]
机构：
[1] UNIV TURIN,AZ OSPED S GIOVANNI BATTISTA,DIP MED & ONCOL SPERIMENTALE,DIV EMATOL,TURIN,ITALY
来源：
BLOOD | 1995年 / 86卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：810 / 810
页数：1
相关论文
共 50 条
  • [21] Long-term follow up of patients with multiple myeloma after high-dose chemotherapy and allogeneic stem cell transplantation
    Rabitsch, W
    Prinz, E
    Ackermann, J
    Wöhrer, S
    Kaufmann, H
    Seidl, S
    Keil, F
    Kalhs, P
    Greinix, H
    Gisslinger, H
    Leitner, G
    Drach, J
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2004, 72 (01) : 26 - 31
  • [22] Cellular in vitro immune function in multiple myeloma patients after high-dose chemotherapy and autologous peripheral stem cell transplantation
    Lindemann, M
    Schuett, P
    Moritz, T
    Ottinger, HD
    Opalka, B
    Seeber, S
    Nowrousian, MR
    Grosse-Wilde, H
    LEUKEMIA, 2005, 19 (03) : 490 - 492
  • [23] Contamination of autologous peripheral blood progenitor cell grafts predicts overall survival after high-dose chemotherapy in multiple myeloma
    Kopp, H. G.
    Yildirim, S.
    Weisel, K. C.
    Kanz, L.
    Vogel, W.
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2009, 135 (04) : 637 - 642
  • [24] Flow cytomertic analysis of multiple myeloma cells in patients treated with high-dose chemotherapy and autologous hematopietic stem cell transplantation
    Awedan, A
    Torosian, T
    Rokicka, M
    Krol, M
    Jedrzejczak, W
    BONE MARROW TRANSPLANTATION, 2003, 31 : S83 - S84
  • [25] Multiple myeloma: reduced plasma cell contamination in peripheral blood progenitor cell collections performed after repeated high-dose chemotherapy courses
    Omede, P
    Tarella, C
    Palumbo, A
    Argentino, C
    Caracciolo, D
    Corradini, P
    Dominietto, A
    Giaretta, F
    Ravaglia, R
    Triolo, R
    Triolo, S
    Pileri, A
    Boccadoro, M
    BRITISH JOURNAL OF HAEMATOLOGY, 1997, 99 (03) : 685 - 691
  • [26] High-dose chemotherapy and autologous blood stem cell transplantation in patients with multiple myeloma and the role of novel agents: A single centre experience
    Fenk, R.
    Neubauer, F.
    Bruns, I.
    Schroeder, T.
    Saure, C.
    Kondakci, M.
    Haas, R.
    Kobbe, G.
    ONKOLOGIE, 2010, 33 : 245 - 245
  • [27] PCR-based monitoring of residual myeloma cells in patients in complete remission after high-dose chemotherapy and allogeneic or autologous transplantation of hematopoietic cells.
    Corradini, P
    Tarella, C
    Voena, C
    Astolfi, M
    Ladetto, M
    Santoro, A
    Bacigalupo, A
    Majolino, I
    Boccadoro, M
    Pileri, A
    BLOOD, 1997, 90 (10) : 4448 - 4448
  • [28] RAPID HEMATOLOGICAL RECOVERY AFTER HIGH-DOSE CONSOLIDATION CHEMOTHERAPY WITH PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC) AS SOLE SOURCE OF SUPPORT COLLECTED AT A SINGLE APHERESIS
    VANHOEF, MEHM
    RANSON, M
    MORGENSTERN, GR
    BAUMANN, I
    LANGE, C
    DEWYNTER, EA
    TESTA, NG
    HOWELL, A
    BONE MARROW TRANSPLANTATION, 1994, 13 (06) : 839 - 840
  • [29] Analysis of circulating tumor cells in patients with multiple myeloma during the course of high-dose therapy with peripheral blood stem cell transplantation
    K Kiel
    FW Cremer
    C Rottenburger
    C Kallmeyer
    E Ehrbrecht
    A Atzberger
    U Hegenbart
    H Goldschmidt
    M Moos
    Bone Marrow Transplantation, 1999, 23 : 1019 - 1027
  • [30] Circulating tumor cells in patients with multiple myeloma prior to and post high-dose therapy and peripheral blood stem cell transplantation.
    Kiel, K
    Cremer, FW
    Ehrbrecht, E
    Atzberger, A
    Kallmeyer, C
    Goldschmidt, H
    Moos, M
    BLOOD, 1997, 90 (10) : 4100 - 4100
12345